Reducing blockages in the pathway to Hepatitis C treatment
Emma Burke, PHE
Current London Picture
Findings from the London Hepatitis C Snapshot:Self reported by London DrugTreatment CommissionersInformation received from 31/32 boroughsSome form of pathway to HCV treatment in place in 20 boroughs (but with widely varying ‘strength’ of pathway)5 boroughs reported pathways in development6 boroughs reported no pathway in place
2
Presentation title - edit in Header and Footer
Reported Blockages to HCV Treatment
Lack of local awareness of referral processes, including GPs and drugs servicesClients not attending appointments at hospitalsHospitalappointment systems not being flexible to the client’sneedsTime delays between appointments / waiting timesNeed for increasedhepatologypresence in drug servicesStigma and myth about HCV and access to HCV treatmentLack of knowledge about HCV amongst service usersService users unwilling to go through ‘harsh’ treatmentHospital staff availability to provide treatment in the community
3
Presentation title - edit in Header and Footer
Reported Blockages to HCVTreatment
Lack of communication betweenhepatologyand drug servicesLack of community based treatment servicesCultural issuesHospital staff perceptions of drug usersLack ofdrug treatment staffskills to test for HCVLack ofdrug treatment staffawareness and / or training availablelocallyLack of clarity between providers on roles and responsibilitiesPatients not being followed upNot enough trained phlebotomists to take venous samples
4
Presentation title - edit in Header and Footer
Aim of workshop: identify solutions to blockages
Using the LJWG Pathway document:Consider what blockages may be encountered at different stages of the pathwaySuggest opportunities and solutions to resolve the blockage, drawing on local experienceIdentify who (role/organisation) may be able to assist taking this forward locallyFeedback 1 blockage and suggested solution(s) per table
5
Presentation title - edit in Header and Footer
0
Embed
Upload